UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

Early-onset Alzheimer's, affecting individuals under 65, presents unique challenges with memory, thinking, and daily ...

Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...

New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 ...

The model reveals that more connected brain regions are more prone to damage, while isolated areas remain resilient. This approach offers a powerful framework for understanding disease progression and ...

Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive ...

Lexington, Massachusetts Tuesday, July 22, 2025, 18:00 Hrs [IST] ...

Mathematics may not be the first thing people associate with Alzheimer’s disease research. But for Pedro Maia, an assistant ...

People with Alzheimer’s have high levels of amyloid-β in their brains, but the team also learned that this was the case in ...

Newborns and individuals with Alzheimer's disease have been found to share an unusual biological feature: both show high ...

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...